Prostate Cancer Research Update: Molecular Diagnostic Biomarkers
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 154
Special Issue Editor
Special Issue Information
Dear Colleagues,
For a long time, methods aimed at diagnosing prostate cancer included the determination of serum PSA levels. Currently, there is an intense debate regarding PSA as a diagnostic, prognostic, and screening tool in PCa due to its limitations. Therefore, it is important to continue searching for molecular markers that can help in early diagnosis and prognosis of the patient's condition, as well as in establishing the patient's response to various treatments, such as new genes, gene fusions, AR variants, non-coding RNAs, and alternatively spliced RNAs.
The aim of this Special Issue is to present the latest advances in the discovery of new molecular biomarkers using transcriptomics, genomics, and epigenetics, which are expected to improve the diagnosis and clinical management of patients with prostate cancer.
Since IJMS is a journal of molecular science, pure clinical studies will not be suitable; however, clinical submissions including biomolecular experiments focusing on the above-mentioned topics are welcomed.
Dr. Mikhail Baryshev
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- molecular biomarkers
- cancer-specific DNA methylation
- non-coding genes
- gene fusions
- lncRNA
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
